Skip to Main Content

Paper Details

Accumulation of Multiple Mutations In Vivo Confers Cross-Resistance to New and Existing Integrase Inhibitors.
Journal of Infectious Diseases
24
2018
BIC, Bictegravir, CAB, DTG, EVG, G140S, HIV, HIV integrase, Integrase, Q148H, RAL, cabotegravir, dolutegravir, elvitegravir, integrase, patient, raltegravir
Author NameAffiliation
P Richard HarriganUniversity of British Columbia
  • 1 - 1

Datasets

Release 1.2